About Us

Human Health!
Through innovative Biomaterial technology

As a subsidiary of the Pusan National University (PNU)
technology holdings company, SNVIA is committed to developing and manufacturing medical microneedle products based on the innovative embeddable microneedle technology.

SNVIA’s embeddable microneedle technology is the world-first medical microneedle platform that enables safe and reliable delivery of drugs through skin without a risk of infection or bleeding.

We’ll put effort and enthusiasm into research and development so as to develop high value medical devices and medicines that can contribute to improving the life of patients by cooperating with pharmaceuticals. With the PNU’s outstanding technology, SNVIA will continue the research and development to be a global venture business.

CEO Howard K.LEE

Leadership

  • YANG, Seung Yun (CEO) / Founder / Ph.D in Polymer Engineering Obtained a Ph.D in polymer engineering at POSTECH and worked as a postdoc at Harvard Medical School.
    Currently he is serving as a associate professor in the Department of Biomaterials and Science at Pusan National University (PNU)
  • Howard K. LEE (CEO) / Co-Founder / BS in Electrical Engineering / MBA /Ph.D Supported incubation and overseas expansion of about 30 IT/SW firms at Korea IT Industry Promotion Agency (currently, NIPA). Conducted more than 40 cases of technology transfer and investment promotion at Chonnam National University and Wonkang University.
  • PARK, Hong Gyun / Co-Founder / MS in Water Resources Engineering In charge of corporate business model development at Daeil Corporate Assessment Center and Gyeonggi TechnoPark. Responsible for technology transfer and technology holding firm foundation, operation, and startup business incubation at Dongguk University.
  • KIM, Se Min (Senior Managing Director) / Ph.D in Mechanical Engineering Obtained a Ph.D in mechanical engineering at Dong-A University. He served as a process management expert of Chemical Plant at the HHI (Hyundai Heavy Industries Co., Ltd.) and OTIS Co., Ltd.

  • Seong, Hak Mo (Director) / Ph.D in Biology Obtained a Ph.D in Biology at Han-Nam Univeisity. He served as a key engineer for production of blood products at Green Cross Inc. And also performed GMP operation and quality management for production of various biomaterial at Bonecellbiotech and Han-nam University
  • Lee, Sung Hee (CFO) / Business Administration BS After majoring in business administration at Seoul National University I worked for Hyundai Electronics Industry (currently Hynix Semiconductor), In charge of Amikogen Co., Ltd. and Genolution IPO Having succeeded in listing two KOSDAQ bio companies